» Articles » PMID: 22426142

Circulating Biomarkers of Iron Storage and Clearance of Incident Human Papillomavirus Infection

Overview
Date 2012 Mar 20
PMID 22426142
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Iron is an essential mineral for both cellular and pathogen survival and is essential for viral replication. In turn, iron metabolism has been shown to be altered by several viral infections. However, little is known about the association between iron status and human papillomavirus (HPV) natural history. We hypothesize iron to be an HPV cofactor that is associated with longer duration of infection.

Methods: Ferritin and soluble transferrin receptor (sTfR) were measured in baseline serum samples from 327 women enrolled in the Ludwig-McGill cohort. Incident HPV clearance rates (any-type, oncogenic HPV, nononcogenic HPV, and HPV-16) over a 3 year time period were estimated from Cox proportional hazard models accounting for correlations between multiple infections.

Results: Women with ferritin levels above the median were less likely to clear incident oncogenic HPV [adjusted hazard ratio (AHR), 0.73; 95% confidence interval (CI), 0.55-0.96] and HPV-16 infections (AHR, 0.29; 95% CI, 0.11-0.73). Using physiologic cutoff points, women with enriched iron stores (>120 μg/L) were less likely to clear incident oncogenic HPV infections than those with low levels of iron (<20 μg/L; AHR, 0.34; 95% CI, 0.15-0.81).

Conclusion: This study observed that women with the highest ferritin levels were less likely to clear incident oncogenic and HPV-16 infections than women with low ferritin. Rising iron stores may decrease probability of clearing new HPV infection, possibly by promoting viral activity and contributing to oxidative DNA damage.

Impact: This novel study suggests that elevated iron stores may put women at risk for persistent HPV infection, an early event in cervical carcinogenesis. Further examination of the association between iron status and HPV natural history is warranted.

Citing Articles

L-shaped association between dietary iron intake and HPV infection: a cross-sectional analysis based on national health and nutrition examination survey 2005-2016.

Chen X, Chen H, Chen Y, Tang L, Liu J, Ou Y Front Nutr. 2025; 12:1530624.

PMID: 40008312 PMC: 11850268. DOI: 10.3389/fnut.2025.1530624.


Phase I study on the pharmacokinetics of intravaginal, self-administered artesunate vaginal pessaries among women in Kenya.

Mungo C, Sorgi K, Misiko B, Ogollah C, Cheserem C, Rahangdale L medRxiv. 2024; .

PMID: 39148845 PMC: 11326355. DOI: 10.1101/2024.07.08.24309596.


The Role of Micronutrients in Human Papillomavirus Infection, Cervical Dysplasia, and Neoplasm.

Ferrari F, Magni F, Bosco M, Biancotto G, Zorzato P, Lagana A Healthcare (Basel). 2023; 11(11).

PMID: 37297793 PMC: 10252691. DOI: 10.3390/healthcare11111652.


Efficacy of Topically Administered Dihydroartemisinin in Treating Papillomavirus-Induced Anogenital Dysplasia in Preclinical Mouse Models.

Gunder L, Blaine-Sauer S, Johnson H, Shin M, Auyeung A, Zhang W Viruses. 2022; 14(8).

PMID: 35893697 PMC: 9332511. DOI: 10.3390/v14081632.


Combined Effect of Secondhand Smoking and Alcohol Drinking on Risk of Persistent Human Papillomavirus Infection.

Seo S, Oh H, Kim M, Lee D, Chung Y, Kim J Biomed Res Int. 2019; 2019:5829676.

PMID: 31016192 PMC: 6448343. DOI: 10.1155/2019/5829676.


References
1.
Koulaouzidis A, Said E, Cottier R, Saeed A . Soluble transferrin receptors and iron deficiency, a step beyond ferritin. A systematic review. J Gastrointestin Liver Dis. 2009; 18(3):345-52. View

2.
Pynaert I, De Bacquer D, Matthys C, Delanghe J, Temmerman M, De Backer G . Determinants of ferritin and soluble transferrin receptors as iron status parameters in young adult women. Public Health Nutr. 2008; 12(10):1775-82. DOI: 10.1017/S1368980008004369. View

3.
Stevens R, Jones D, Micozzi M, Taylor P . Body iron stores and the risk of cancer. N Engl J Med. 1988; 319(16):1047-52. DOI: 10.1056/NEJM198810203191603. View

4.
Casabellata G, Di Santolo M, Banfi G, Stel G, Gonano F, Cauci S . Evaluation of iron deficiency in young women in relation to oral contraceptive use. Contraception. 2007; 76(3):200-7. DOI: 10.1016/j.contraception.2007.04.016. View

5.
Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F . A review of human carcinogens--Part B: biological agents. Lancet Oncol. 2009; 10(4):321-2. DOI: 10.1016/s1470-2045(09)70096-8. View